Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
US11090375B2 · kind B2 · utility
5Cited by
38References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 12, 2020 |
| Grant date | Aug 17, 2021 |
| Priority date | — |
| Expiry date | Jun 12, 2040 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to new immunogenic compositions comprising conjughated Streptococcus pneumoniae capsular saccharide antigens (glycoconjugates) and uses thereof. Immunogenic compositions of the present invention will typically comprise at least one glycoconjugate from a S. pneumoniae serotype not found in PREVNAR®, SYNFLORIX® and/or PREVNAR 13®. The invention also relates to vaccination of human subjects, in particular infants and elderly, against pneumococcal infections using said novel immunogenic compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.